Quest Diagnostics has announced the launch of an at-home Covid-19 rapid antigen test service offered for consumer purchase through its consumer-initiated testing platform, QuestDirect. 

In partnership with eMed, the latest service includes proctored telehealth, which features a trained technician to ensure correct sample collection, verify identity and certify the reported results during the telehealth visit.

The offering allows the Abbott BinaxNOW COVID-19 Ag Card Home Test to be used under the supervision of a certified telehealth proctor and an eMed laboratory report to be provided to the user.

These reports could be used for international travel, confirming positive results to facilitate prescription treatment by a doctor and return to work or school programmes in settings where proctored Covid-19 tests are needed.

Each test comes with certified telehealth proctoring which can be used at any time and from anywhere in the world. 

How well do you really know your competitors?

Access the most comprehensive Company Profiles on the market, powered by GlobalData. Save hours of research. Gain competitive edge.

Company Profile – free sample

Thank you!

Your download email will arrive shortly

Not ready to buy yet? Download a free sample

We are confident about the unique quality of our Company Profiles. However, we want you to make the most beneficial decision for your business, so we offer a free sample that you can download by submitting the below form

By GlobalData
Visit our Privacy Policy for more information about our services, how we may use, process and share your personal data, including information of your rights in respect of your personal data and how you can unsubscribe from future marketing communications. Our services are intended for corporate subscribers and you warrant that the email address submitted is your corporate email address.

Adults and children from the age of four years can use the self-administered nasal swab antigen test, which delivers results in 15 minutes.

Quest Diagnostics clinical franchise solutions and marketing senior vice-president and group executive Cathy Doherty said: “Consumers and employers seek reliable, fast and easy testing solutions to help limit exposure to Covid-19 and ensure safer travelling and return to work. 

“This QuestDirect offering complements our molecular laboratory testing services to increase access, convenience and flexibility to diagnostic insights. 

“As a leader in the nation’s Covid-19 testing response, Quest Diagnostics is continually looking to broaden access to quality Covid-19 diagnostic insights, and this collaboration with eMed expands our ability to help individuals across the US meet the challenge of Covid-19.”

Furthermore, the company is partnering with digital health firm Truepill to fulfil and deliver orders.

Due to the API-connected digital health platform and countrywide pharmacy footprint of Truepill, users will be able to obtain test kits within two to three business days of purchase.

In April 2020, Quest and Centene collaborated to extend real-time reverse transcription-polymerase chain reaction Covid-19 testing across the US.